Marc Benioff - Jul 22, 2021 Form 4 Insider Report for SALESFORCE.COM, INC. (CRM)

Signature
/s/ Anisha Mehta, Attorney-in-Fact for Marc Benioff
Stock symbol
CRM
Transactions as of
Jul 22, 2021
Transactions value $
-$3,748,399
Form type
4
Date filed
7/23/2021, 05:41 PM
Previous filing
Jul 22, 2021
Next filing
Jul 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $1.19M +20K +0.07% $59.34 29M Jul 22, 2021 Direct F1, F2
transaction CRM Common Stock Sale -$183K -752 0% $243.62 29M Jul 22, 2021 Direct F1, F2, F3
transaction CRM Common Stock Sale -$1.25M -5.09K -0.02% $245.35 29M Jul 22, 2021 Direct F1, F2, F4
transaction CRM Common Stock Sale -$640K -2.6K -0.01% $246.22 29M Jul 22, 2021 Direct F1, F2, F5
transaction CRM Common Stock Sale -$1.33M -5.4K -0.02% $247.18 29M Jul 22, 2021 Direct F1, F2, F6
transaction CRM Common Stock Sale -$1.53M -6.16K -0.02% $248.17 29M Jul 22, 2021 Direct F1, F2, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -20K -1.38% $0.00 1.43M Jul 22, 2021 Common Stock 20K $59.34 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
F2 Other than the shares subject to the transactions reported in this Form 4 (which are held in the reporting person's name), shares are held in the Marc R. Benioff Revocable Trust.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $243.5000 to $244.3200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $244.7700 to $245.7500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Weighted average price. These shares were sold in multiple transactions at prices ranging from $245.8200 to $246.7600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 Weighted average price. These shares were sold in multiple transactions at prices ranging from $246.8200 to $247.8000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 Weighted average price. These shares were sold in multiple transactions at prices ranging from $247.8300 to $248.6200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8 Option vests over four years at the rate of 25% on November 25, 2015, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.